Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Earnings Release 2013

Oct 31, 2013

30403_rns_2013-10-31_2166fe69-fcc7-428d-8df1-4def059fe1f0.zip

Earnings Release

Open in viewer

Opens in your device viewer

8-K 1 clorox_8k.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 ________

FORM 8-K

CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 31, 2013

THE CLOROX COMPANY (Exact name of registrant as specified in its charter)


Delaware 1-07151 31-0595760
(State or other jurisdiction
of (Commission File Number) (I.R.S. Employer
incorporation) Identification
No.)

| 1221 Broadway, Oakland,
California | 94612-1888 |
| --- | --- |
| (Address of principal executive
offices) | (Zip
code) |

(510) 271-7000 (Registrant's telephone number, including area code)

Not applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition

On October 31, 2013, The Clorox Company issued a press release announcing its financial results for its first quarter ended September 30, 2013. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure

Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit Description
99.1 Press Release dated October 31, 2013 of
The Clorox Company
99.2 Supplemental information regarding financial
results

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CLOROX COMPANY — By:
Senior Vice President –
General
Counsel

THE CLOROX COMPANY

FORM 8-K

INDEX TO EXHIBITS

Exhibit Description
99.1 Press Release dated October 31, 2013 of The Clorox
Company
99.2 Supplemental Information